Showing results (151-160 of 1,983) with videos related to
Sort By:
Pageof 199
Breast (Edinburgh, Scotland)|September 24, 2023
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trialMaiyue He, Jiaxuan Liu, Zijing Wang, et al.International Journal of Cancer|September 7, 2023
Efficacy and safety of apatinib combined with dose-dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple-negative breast cancer: A prospective cohort study with propensity-matched analysisJiaxuan Liu, Maiyue He, Kaiping Ou, et al.Annals of Translational Medicine|February 11, 2021
Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasisYimeng Chen, Yin Guan, Jiayu Wang, et al.Medicine|August 7, 2016
Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in ChinaJiuda Zhao, Feng Du, Yu Zhang, et al.Cancer Communications (London, England)|October 12, 2019
Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancerShaoyan Lin, Jian Yue, Xiuwen Guan, et al.Cancer Biology & Medicine|September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancerQi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 3, 2016
Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in ChinaJiuda Zhao, Junhui Zhao, Feng Du, et al.Clinical Breast Cancer|December 5, 2020
Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based AnalysisYiqun Han, Jiayu Wang, Yanxia Sun, et al.Breast Cancer Research and Treatment|September 17, 2025
Pathological complete response and survival outcomes in single hormone receptor-positive/HER2-negative breast cancer after neoadjuvant chemotherapy and its intrinsic biological features and immune landscapeLei Ji, Xi Chen, Hongwei Lyu, et al.American Journal of Cancer Research|September 13, 2024
Evolution and prognostic significance of HER-2 conversion from primary to residual disease in HER-2 negative patients with breast cancer after neoadjuvant chemotherapyXi Chen, Lei Ji, Xiaoyan Qian, et al.Pageof 199